98%
921
2 minutes
20
Purpose: We aimed to assess the clinical efficacy of transcatheter arterial embolization (TAE) for treating hemothorax caused by chest trauma.
Materials And Methods: Between 2015 and 2019, 68 patients (56 male; mean age, 58.2 years) were transferred to our interventional unit for selective TAE to treat thoracic bleeding. We retrospectively investigated their demographics, angiographic findings, embolization techniques, technical and clinical success rates, and complications.
Results: Bleeding occurred mostly from the intercostal arteries (50%) and the internal mammary arteries (29.5%). Except one patient, TAE achieved technical success, defined as the immediate cessation of bleeding, in all the other patients. Four patients successfully underwent repeated TAE for delayed bleeding or increasing hematoma after the initial TAE. The clinical success rate, defined as no need for thoracotomy for hemostasis after TAE, was 92.6%. Five patients underwent post-embolization thoracotomy for hemostasis. No patient developed major TAE-related complications, such as cerebral infarction or quadriplegia.
Conclusion: TAE is a safe, effective and minimally invasive method for controlling thoracic wall and intrathoracic systemic arterial hemorrhage after thoracic trauma. TAE may be considered for patients with hemothorax without other concomitant injuries which require emergency surgery, or those who undergoing emergency TAE for abdominal or pelvic hemostasis.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9514418 | PMC |
http://dx.doi.org/10.3348/jksr.2020.0116 | DOI Listing |
Eur Radiol
September 2025
Department of Anesthesiology and Intensive Care Medicine, University Hospital Leipzig, Liebigstr. 20, 04103, Leipzig, Germany.
Objectives: Contrast extravasation on imaging studies is a clinical surrogate for bleeding severity. However, the prognostic relevance of this imaging sign needs to be evaluated. The aim of this study was to analyze the impact of contrast extravasation defined by computed tomography (CT) and angiography on massive transfusion and 30-day mortality in patients with acute bleeding undergoing transarterial embolization (TAE).
View Article and Find Full Text PDFJ Vasc Interv Radiol
September 2025
Department of Radiology, Division of Interventional Radiology, Memorial Sloan Kettering Cancer Center, New York, NY, USA. Electronic address:
J Chromatogr A
August 2025
Waters Corporation, Core Research/Fundamental Milford, MA, 01757, USA.
Slalom chromatography (SC) has recently been revitalized through the latest available UHPLC columns and systems, alongside advances in better understanding its separation and mass transfer mechanisms. These developments have demonstrated its potential in the analysis of cell and gene therapy drug substances, including plasmid topology analysis, DNA restriction mapping, dsRNA impurity detection in IVT mRNA, and CRISPR-Cas9 ribonucleoprotein assays. However, SC's quantitative superiority over traditional agarose gel electrophoresis (AGE) remains unproven, and no accurate and predictive model has yet been reported for any commercial SC column for a wide range of experimental conditions of temperature, flow rate, and buffer concentration.
View Article and Find Full Text PDFInvestig Clin Urol
September 2025
This corrects the article on p. 219 in vol. 64, PMID: 37341002.
View Article and Find Full Text PDFNanoscale Adv
August 2025
Department of Physics, Jeonbuk National University Jeonju 54896 Republic of Korea
The chemical and atomic structures of Cu-, Ni-, or CuNi-embedded MXene (TiCT , T = O or OH) nanosheet catalysts are examined by using various characterization methods to demonstrate the chemical origin of their composition-dependent evolution. The results of combined X-ray spectroscopy studies and the electrochemical test reveal that Cu ions in (Cu or CuNi):MXene remain active having a +1 valence and form metallic Cu-Cu bonds to enhance the catalytic activity for nitrate reduction. By contrast, Ni ions in (Ni or CuNi):MXene tend to remain bound to O as in NiO staying inactive, and, furthermore, hinder the catalytic activity of Cu when co-doped on MXene.
View Article and Find Full Text PDF